Navigation Links
Evaluating The Risks and Benefits of Hormone Therapy

In a study done on the risks and benefits of short-term use of hormone therapy in menopausal women it was found that women can // increase their quality of life, but they may also shorten their life expectancy if they use hormone therapy.

Deciding whether or not to use hormone therapy can be a difficult decision. Hormone therapy can be an effective treatment for menopausal symptoms, but are the risks worth the benefits? Question researchers . In a recent study conducted researchers investigated the precise risks and benefits of short-term hormone therapy .

For the study, researchers developed a Web-based computer model to simulate the effects of two years of hormone therapy use. They looked at life expectancy and the improved quality of life among 50-year-old menopausal women. The computer model was based on findings from the Women’s Health Initiative, a 15-year-long research project.

It was observed that for women without any menopausal symptoms, short term hormone therapy resulted in a net loss in life expectancy and quality of life expectancy of one to three months. Women with symptoms gained seven to eight months of improved quality of life, but a shortened overall survival.

Researchers conclude saying that short-term hormone therapy can be both harmful and beneficial. The decision to use it depends on a woman’s treatment goals. If the goal is to maximize the quality of life, then hormone therapy is beneficial. However, if the goal is to live longer, they do not recommend hormone therapy.
'"/>




Page: 1

Related medicine news :

1. Evaluating The Risk Factors Of Osteoporosis
2. Evaluating The Benefits Of A Low – carb Diet
3. Simvastatin Plus Niacin May Lower Heart Risks
4. Risks for Silent Strokes
5. Ginseng Associated with Pregnancy Risks
6. Benefits and Risks of Asthma Treatment Questioned
7. Lack of Smell And Its Potential Risks
8. A Slight Increase In BP Can Mean big Risks
9. The Risks Of Smoking
10. Risks Of An Enlarged Heart
11. Identifying The Risks Of Developing Schizophrenia

Post Your Comments:
(Date:11/28/2009)...swire/ -- Get ready for advanced visualization ... when Siemens introduces syngo. via(1) a...of the Radiological Society of North America (RSNA...e (Booth #825, East Building/Lakeside Center, Hall... new imaging software for multimodality reading of...
(Date:11/28/2009)...o affect circadian rhythm, , , FRID...sts that an internal body clock that goes on the f...ar disorder in children. , The finding results... children with bipolar disorder, which can make pe...ldren without the disorder. They linked variations...
(Date:11/27/2009)... GSI Group Inc. (Pink She...n technology products and semiconductor systems, t...ny,s shareholders has been scheduled for Friday, A...ng will be announced in due course. As previously...ice from Stephen Bershad, a holder of greater than...
(Date:11/27/2009)...m Replikins Ltd. today issued its latest biochemic...ows that the lethality of the virus has dropped fr...urrent outbreak in the spring of 2009 to resting n...e H1N1 infectivity count, however, remains increas...mber 27, 2009 -- Biotech firm Replikins Ltd., whic...
(Date:11/27/2009)...Newswire-FirstCall/ -- The Gymboree Corporation (N...OO, will present at the NASDAQ OMX 23rd Investor P...n London, England, on Wednesday, December 2, 2009,...dcast of The Gymboree Corporation,s presentation o...m, click on "Our Company" at the bottom of the pag...
Breaking Medicine News(10 mins):Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5
...king place, experts say , , THURSDAY, Sept...ng to heal psychologically -- as much as it is pos... on the World Trade Center towers on Sept. 11, 200... happened over the past seven years is we,re seein...
... Non-US Healthcare Media, - Global QUEST Study Re...ificantly Improved Survival Outcomes With Vetmedin...e today welcoming new research that,delivers the p...st common type of heart failure live on average 91...
...vices, Inc. (NYSE: ACS ) today announced that it ...nce Program (EPAP), now activated for,residents in...v., The EPAP program, established by the Centers ...surance living in, or,evacuated from, declared fed...
...pular,types of health care coverage are projected ...inder of 2008 and into 2009, according to a nation...are among the results of a survey released today b...ealth,insurers, HMOs and third-party administrator...
...rstCall/ - DiagnoCure Oncology,Laboratories, a sub...ship,of the Colon Cancer Alliance,s (CCA) inaugura...ght Colon Cancer" being held in Philadelphia, PA,o...e at the "Championship Level" to coincide with the...
... Phase 3 Clinical Trial, VALENCIA, Calif., Sept. ...nounced that it will host an analyst day,for the i...m Phase 3 and,other clinical trials of the company... access the live audio broadcast or,the subsequent...
Other Medicine News:Health News:9/11's Psychological Scars Slowly Healing 2Health News:9/11's Psychological Scars Slowly Healing 3Health News:9/11's Psychological Scars Slowly Healing 4Health News:Landmark Research Heralds New Era in Dog Heart Treatment and Longer Life for Dogs 2Health News:Landmark Research Heralds New Era in Dog Heart Treatment and Longer Life for Dogs 3Health News:Landmark Research Heralds New Era in Dog Heart Treatment and Longer Life for Dogs 4Health News:ACS Facilitates Emergency Prescription Assistance Program Now Activated in Southern Louisiana 2Health News:Health Care Cost Increases to Continue at Double Digit Rates, According to Buck Consultants Survey 2Health News:Health Care Cost Increases to Continue at Double Digit Rates, According to Buck Consultants Survey 3Health News:Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test 2Health News:Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test 3Health News:Diagnocure announces sponsorship of inaugural undy 5,000 run - Partnership with the Colon Cancer Alliance creates patient awareness of previstage(TM) GCC staging test 4Health News:MannKind Corporation to Host Webcast Analyst Day September 16, 2008 2
(Date:11/29/2009)...CAGO, Nov. 29 FUJIFILM Medical Sys..., its revolutionary flat panel DR cassette, at the... Annual Meeting. Ideal for any clinical environme... provide clinicians with Fujifilm,s trademark imag...VO is a smart way for users to transition to DR wi...
(Date:11/29/2009)...CAGO, Nov. 29 Researchers using fu...y brain activation have found that men and women r...i, according to a study presented today at the ann...merica (RSNA). ,, "Men may direct more attentio... to process them in terms of implications for requ...
(Date:11/27/2009)...MINGTON, Minn, Nov. 27 ACUO TECHNO...ge management software, data migration tools and s...ates Patent and Trademark Office has approved a pa...t within a Computer Network." Acuo Technologies is...f intellectual property. In general, the granted p...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 1QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 2QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 3QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 4Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 1Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 2Rib X Pharmaceuticals to Present at the 49th ICAAC 13970 1Rib X Pharmaceuticals to Present at the 49th ICAAC 13970 2Rib X Pharmaceuticals to Present at the 49th ICAAC 13970 3Rib X Pharmaceuticals to Present at the 49th ICAAC 13970 4
... Eli Lilly and Company announced today that Phase...ZAR(R) (gemcitabine HCl for injection) to the curr...ificant increase in progression-free survival at t...l cancer. , , Cervical cancer is the world,s se...he second most common cause of cancer death in wom...
... Data from the Phase III ZODIAC study in advanced ...stigational drug vandetanib, were presented today ...) meeting in Orlando. Results show that the study ...ddition of vandetanib to docetaxel resulted in a s...n-free survival (PFS), the length of time a patien...
Other Medicine Technology:Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 2Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 3Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 4Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 6Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 2Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 3Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 4Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 5
...HME product line has the right product for any pat...tubated patients to patients with tracheotomies. T...th anesthesia and critical care applications., ,T...rotection for patients and staff members. This ent...
...HME product line has the right product for any pat...tubated patients to patients with tracheotomies. T...th anesthesia and critical care applications., ,T...rotection for patients and staff members. This ent...
High Performance HME with Port
Breathe-Easy™ with Suction Valve for Tracheotomies
Medicine Products: